Second-line erlotinib for non-small-cell lung cancer

Research output: Contribution to journal › Article › peer-review

ASJC Scopus subject areas

@article{9701749f639b4d71b3c131246c4ad62b,

title = "Second-line erlotinib for non-small-cell lung cancer",

author = "Vito Lorusso and Saverio Cinieri",

year = "2012",

month = apr,

doi = "10.1016/S1470-2045(12)70113-4",

language = "English",

volume = "13",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "4",

}

TY - JOUR

T1 - Second-line erlotinib for non-small-cell lung cancer

AU - Lorusso, Vito

AU - Cinieri, Saverio

PY - 2012/4

Y1 - 2012/4

UR - http://www.scopus.com/inward/record.url?scp=84859134673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859134673&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(12)70113-4

DO - 10.1016/S1470-2045(12)70113-4

M3 - Article

C2 - 22469123

AN - SCOPUS:84859134673

VL - 13

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 4

ER -